| Synonym |
| Thai / English name |
Part Used : -Activity : CYP2C19 INHIBITIONSolvent/Active Compound : dichloromethane extract, ethanol extractType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark :Note : Andrographis paniculata (AP) ethanol extract and Centella asiatica (CA) dichloromethane extract exhibited mixed type inhibition towards CYP2C19 with Ki values of 67.1 and 16.4 microgram/ml respectively; CA ethanol extract and Orthosiphon stamineus (OS) petroleum ether extract competitively CYP2C19 activity (Ki =39.6 and 41.5 microgram/ml respectively). Eupatorin (a major active constituent of OS) was found to significantly inhibit CYP2C19 by mixed type inhibition (Ki=7.1 microgram/ml or 20.6 micromolar
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : aqueousType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 615.1 microgram/ml
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : ethanolType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 61.2 microgram/ml
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : dichloromethaneType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 30.2 microgram/ml - Moderate inhibition was observed with C. asiatica dichloromethane extract. Therefore care should be taken when these C. asiatica components are co-administered with CYP2C19 substrates (such as omeprazole, proguanil, barbiturates, citalopram, and diazepam)
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : hexaneType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 112.5 microgram/ml
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : asiatic acidType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 117.5 microgram/ml (240.4 micromolar)
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : asiaticosideType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 408.3 microgram/ml (425.7 micromolar)
Part Used : ไม่ระบุActivity : CYP2C19 INHIBITIONSolvent/Active Compound : madecassic acidType of experiment : in vitroType of animal : -Type of study : -N(Total) : -N(Treatment) : -Sex : -Age : -Route : -Dose/Conc.(herb) : -Duration : -Type of interaction : PharmacokineticsInteraction with drug : -Dose/Conc.(drug) : -Result : PositiveRemark : - IC50 = 92.5 microgram/ml (183.3 micromolar)
